ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

House panel gives NIH 0.5 percent increase, matching the President’s budget request.

June 17, 2005

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

In Brief: Durant To Retire From ASCO In A Year; Led Society Through Management Change

July 24, 1998

Four New DCCP Abs Established Without New Slots, More Money

January 15, 1982

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Cancer Policy: Board Advocates $2 Per Pack Raise For Cigarettes

January 16, 1998